NAVEGAL LABORATORIES products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad-based pharmaceutical company engaged in development, manufacturing and marketing of generic medicines.
NAVEGAL LABORATORIES products in Pakistan
NAVEGAL LABORATORIES has 110 medicine presentations registered in Pakistan under 53 brands, covering 51 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Oncology & immunology. Its brands with the most registered strengths and packs are Quit (Quetiapine), Alphado (Olanzapine + Fluoxetine), Caron (Iron polymaltose complex + Folic acid, Iron + Folic acid) and Cinvop (Aprepitant). 110 products have an official DRAP price on MedInfoBase. See all 53 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- 4th Floor, Plaza 42, Wisteria Road, Sector A, near World Trade Center, DHA Phase II, Islamabad, Pakistan
- Website
- navegal.com.pk ↗
- Phone
- +92 51 5147148-49
- info@navegal.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 17 Oct 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where NAVEGAL LABORATORIES is priced against the market
100 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Alitis Tablets 10mgRegistry verified | Ebastine | — | — | — | 043945Official source ↗ | No indexed price | — | — |
| Alphad | Fluoxetine | 20 mg | Capsule | 10 | 043961 | PKR 120.03 | PKR 12.00/capsule | 🔒 Pharma Pro |
| Alphado | Olanzapine + Fluoxetine | 25 mg + 6 mg | Capsule | 10 | 093905 | PKR 288.07 | PKR 28.81/capsule | 🔒 Pharma Pro |
| Alphado | Olanzapine + Fluoxetine | 25 mg + 6 mg | Capsule | 30 | 093905 | PKR 794.03 | PKR 26.47/capsule | 🔒 Pharma Pro |
| Alphado | Olanzapine + Fluoxetine | 25 mg + 6 mg | Capsule | 14 | 093905 | PKR 402.56 | PKR 28.75/capsule | 🔒 Pharma Pro |
| Alphado | Olanzapine + Fluoxetine | 25 mg + 6 mg | Capsule | 20 | 093905 | PKR 546.59 | PKR 27.33/capsule | 🔒 Pharma Pro |
| Armicap | Artemether + Lumefantrine | 40 mg + 240 mg | Capsule | 8 | 068242 | PKR 487.50 | PKR 60.94/capsule | 🔒 Pharma Pro |
| Armisin | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 16 | 056834 | PKR 590.91 | PKR 36.93/tablet | 🔒 Pharma Pro |
| Armisin | Artemether | 80 mg | Injection | 1ml x 5 | 101399 | PKR 886.36 | PKR 177.27/mL | 🔒 Pharma Pro |
| Ashmol | Paracetamol + Chlorpheniramine + Caffeine | 500 mg + 2 mg + 65 mg | Tablet | 200 | 056583 | PKR 557.86 | PKR 2.79/tablet | No comparator |
| Ashmol | Paracetamol + Chlorpheniramine + Caffeine | 500 mg + 2 mg + 65 mg | Tablet | 100 | 056583 | PKR 281.49 | PKR 2.81/tablet | No comparator |
| Astrolex | Anastrozole | 1 mg | Tablet | 30 | 097164 | PKR 10,193.15 | PKR 339.77/tablet | 🔒 Pharma Pro |
| Bactiza Injection 2.5gmRegistry verified | Avibactam as Sodium, Ceftazidime as Pentahydrate | — | — | — | 135027Official source ↗ | No indexed price | — | — |
| Belum | Lamivudine | 100 mg | Tablet | 14 | 056584 | PKR 553.98 | PKR 39.57/tablet | 🔒 Pharma Pro |
| Berib | Ribavirin | 400 mg | Tablet | 10 | 056585 | PKR 166.19 | PKR 16.62/tablet | 🔒 Pharma Pro |
| Bleex | Tranexamic acid | 500 mg | Capsule | 20 | 078477 | PKR 358.24 | PKR 17.91/capsule | 🔒 Pharma Pro |
| Bupress XL | Bupropion | 300 mg | Tablet | 20 | 093906 | PKR 923.29 | PKR 46.16/tablet | 🔒 Pharma Pro |
| Bupress XL | Bupropion | 150 mg | Prolonged-release tablet | 7 | 116244 | PKR 193.89 | PKR 27.70/tablet | No comparator |
| Caron | Iron polymaltose complex + Folic acid | 100 mg elemental iron + 0.35 mg folic acid | Tablet | 10 | 043974 | PKR 129.26 | PKR 12.93/tablet | 🔒 Pharma Pro |
| Caron | Iron polymaltose complex + Folic acid | 100 mg elemental iron + 0.35 mg folic acid | Tablet | 30 | 043974 | PKR 372.27 | PKR 12.41/tablet | 🔒 Pharma Pro |
| Caron | Iron polymaltose complex + Folic acid | 100 mg + 0.35 mg | Capsule | 30 | 056830 | PKR 353.66 | PKR 11.79/capsule | 🔒 Pharma Pro |
| Caron | Iron + Folic acid | 100 mg elemental iron + 0.35 mg | Capsule | 20 | 056830 | PKR 245.60 | PKR 12.28/capsule | No comparator |
| Cinvop | Aprepitant | 40 mg | Capsule | 2 | 101404 | PKR 1,791.19 | PKR 895.60/capsule | 🔒 Pharma Pro |
| Cinvop | Aprepitant | 80 mg | Capsule | 2 | 101405 | PKR 2,991.47 | PKR 1,495.74/capsule | 🔒 Pharma Pro |
| Cinvop | Aprepitant | 125 mg | Capsule | 2 | 101406 | PKR 4,671.86 | PKR 2,335.93/capsule | 🔒 Pharma Pro |
| Cinvop | Aprepitant | 125 mg | Capsule | 1 | 101406 | PKR 2,335.93 | PKR 2,335.93/capsule | 🔒 Pharma Pro |
| Clozegal | Clozapine | 100 mg | Tablet | 5x10's | 110404 | PKR 3,231.52 | PKR 64.63/tablet | 🔒 Pharma Pro |
| Clozegal | Clozapine | 25 mg | Tablet | 5x10's | 110405 | PKR 1,477.27 | PKR 29.55/tablet | 🔒 Pharma Pro |
| Defrx | Deferasirox | 250 mg | Tablet | 28 | 100337 | PKR 8,099.12 | PKR 289.25/tablet | 🔒 Pharma Pro |
| Defrx | Deferasirox | 250 mg | Tablet | 1 | 100337 | PKR 288.07 | PKR 288.07/tablet | 🔒 Pharma Pro |
| Defrx | Deferasirox | 500 mg | Tablet | 28 | 100338 | PKR 13,443.14 | PKR 480.11/tablet | 🔒 Pharma Pro |
| Defrx | Deferasirox | 500 mg | Tablet | 1 | 100338 | PKR 480.11 | PKR 480.11/tablet | 🔒 Pharma Pro |
| Derizo | Voriconazole | 200 mg | Tablet | 10 | 101401 | PKR 2,031.24 | PKR 203.12/tablet | 🔒 Pharma Pro |
| Derog Dry syp/susp | Cephalexin | 250 mg/5 mL | Dry suspension | 60ml | 043935 | PKR 129.26 | PKR 2.15/mL | 🔒 Pharma Pro |
| Derog Dry syp/susp | Cephalexin | 125 mg/5 mL | Dry suspension | 60ml | 043936 | PKR 73.86 | PKR 1.23/mL | 🔒 Pharma Pro |
| Didacon | Fluconazole | 150 mg | Tablet | 1 | 043947 | PKR 254.83 | PKR 254.83/tablet | 🔒 Pharma Pro |
| Dixico | Ofloxacin | 400 mg | Tablet | 10 | 043939 | PKR 276.99 | PKR 27.70/tablet | 🔒 Pharma Pro |
| Dixico | Ofloxacin | 200 mg | Tablet | 10 | 043943 | PKR 212.36 | PKR 21.24/tablet | 🔒 Pharma Pro |
| Durevo | Omeprazole | 40 mg | Tablet | 14 | 043927 | PKR 461.65 | PKR 32.98/tablet | 🔒 Pharma Pro |
| Durevo | Omeprazole | 20 mg | Tablet | 14 | 043928 | PKR 265.91 | PKR 18.99/tablet | 🔒 Pharma Pro |
| Effo 500mg IV InjectionRegistry verified | Cefepime HCI with L-arginine | — | — | — | 045438Official source ↗ | No indexed price | — | — |
| Elimnar Injection 2.25gm (IV)Registry verified | Piperacillin as Sodium, Tazobactam as Sodium | — | — | — | 130753Official source ↗ | No indexed price | — | — |
| Elimnar Injection 4.5gm (IV)Registry verified | Piperacillin as Sodium, Tazobactam as Sodium | — | — | — | 130752Official source ↗ | No indexed price | — | — |
| Evrilus | Everolimus | 10 mg | Tablet | 50 | 097158 | PKR 172,258.72 | PKR 3,445.17/tablet | 🔒 Pharma Pro |
| Fenotal | Phenobarbital | 30 mg | Tablet | 60 | 079323 | PKR 45.56 | PKR 0.76/tablet | 🔒 Pharma Pro |
| Galdrop-D | Cholecalciferol | 5 mg | Injection | 1ml x 5 | 101398 | PKR 862.36 | PKR 172.47/mL | 🔒 Pharma Pro |
| Galdrop-D | Cholecalciferol | 5 mg | Injection | 1ml x 1 | 101398 | PKR 172.47 | PKR 172.47/mL | 🔒 Pharma Pro |
| Galnem Injection 1gmRegistry verified | Meropenem (as trihydrate) (Blended with sodium carbonate) | — | — | — | 108914Official source ↗ | No indexed price | — | — |
| Galnem Injection 500mgRegistry verified | Meropenem (as trihydrate) (Blended with sodium carbonate) | — | — | — | 108913Official source ↗ | No indexed price | — | — |
| Galpa-Q | Hydroxychloroquine | 200 mg | Tablet | 50 | 101275 | PKR 830.96 | PKR 16.62/tablet | 🔒 Pharma Pro |
All 53 NAVEGAL LABORATORIES brands in Pakistan
- Alphad Fluoxetine · 20 mg capsule
- Alphado Olanzapine + Fluoxetine · 25 mg + 6 mg capsule
- Armicap Artemether + Lumefantrine · 40 mg + 240 mg capsule
- Armisin Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 80 mg injection
- Ashmol Paracetamol + Chlorpheniramine + Caffeine · 500 mg + 2 mg + 65 mg tablet
- Astrolex Anastrozole · 1 mg tablet
- Belum Lamivudine · 100 mg tablet
- Berib Ribavirin · 400 mg tablet
- Bleex Tranexamic acid · 500 mg capsule
- Bupress XL Bupropion · 150 mg tablet, 300 mg tablet
- Caron Iron polymaltose complex + Folic acid, Iron + Folic acid · 100 mg + 0.35 mg capsule, 100 mg elemental iron + 0.35 mg capsule, 100 mg elemental iron + 0.35 mg folic acid tablet
- Cinvop Aprepitant · 125 mg capsule, 40 mg capsule, 80 mg capsule
- Clozegal Clozapine · 100 mg tablet, 25 mg tablet
- Defrx Deferasirox · 250 mg tablet, 500 mg tablet
- Derizo Voriconazole · 200 mg tablet
- Derog Dry syp/susp Cephalexin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
- Didacon Fluconazole · 150 mg tablet
- Dixico Ofloxacin · 200 mg tablet, 400 mg tablet
- Durevo Omeprazole · 20 mg tablet, 40 mg tablet
- Evrilus Everolimus · 10 mg tablet
- Fenotal Phenobarbital · 30 mg tablet
- Galdrop-D Cholecalciferol · 5 mg injection
- Galpa-Q Hydroxychloroquine · 200 mg tablet
- Lamiga Lamotrigine = · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Lecar Carbidopa + Levodopa · 250 mg + 25 mg tablet
- Lecar Plus Carbidopa + Levodopa + Entacapone · 200 mg + 50 mg + 200 mg tablet
- Lenvox Linezolid · 600 mg tablet
- Levitab Levetiracetam · 250 mg tablet, 500 mg tablet
- Manep Carbamazepine · 200 mg tablet
- Metalip Vildagliptin + Metformin · 50 mg + 1000 mg tablet, 50 mg + 850 mg tablet
- Modiziz Methotrexate · 10 mg tablet, 2.5 mg tablet
- Navelox Moxifloxacin · 400 mg tablet
- Navexim Cefixime · 400 mg capsule
- Navexim Dry syp Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension
- Ofira Tenofovir disoproxil · 300 mg tablet
- Pipin Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Previr Entecavir · 0.5 mg tablet, 1 mg tablet
- Pudex Ciprofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Quit Quetiapine · 200 mg tablet, 25 mg tablet
- Quit XR Quetiapine · 300 mg tablet
- Sinex Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Sirj Amlodipine + Valsartan · 10 mg + 160 mg tablet, 5 mg + 160 mg tablet, 5 mg + 80 mg tablet
- Sirj-H Amlodipine + Valsartan + Hydrochlorothiazide · 10 mg + 160 mg + 12.5 mg tablet, 10 mg + 160 mg + 25 mg tablet, 5 mg + 160 mg + 12.5 mg tablet
- Stimfer Letrozole · 2.5 mg tablet
- Supcyt Valganciclovir · 450 mg tablet
- Suudi Ibuprofen + Pseudoephedrine · 200 mg + 30 mg tablet
- Taclekin Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
- Timigra Sodium valproate · 200 mg tablet, 500 mg tablet
- Uneek Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Vestire Clarithromycin · 250 mg tablet, 500 mg tablet
- Virluza Oseltamivir · 75 mg capsule
- Zelide Azithromycin · 250 mg capsule, 500 mg capsule
- Zepavan Lorazepam · 1 mg tablet, 2 mg tablet
NAVEGAL LABORATORIES: common questions
How many products does NAVEGAL LABORATORIES have in Pakistan?
NAVEGAL LABORATORIES has 110 registered medicine presentations in Pakistan, sold under 53 brands and covering 51 generic medicines.
What are the main brands of NAVEGAL LABORATORIES?
By number of registered strengths and packs, its largest brands are Quit (Quetiapine), Alphado (Olanzapine + Fluoxetine), Caron (Iron polymaltose complex + Folic acid, Iron + Folic acid), Cinvop (Aprepitant) and Defrx (Deferasirox). This is not a sales ranking.
Which therapy areas does NAVEGAL LABORATORIES cover?
The most products are in Anti-infectives (39), CNS & mental health (28), Oncology & immunology (10), Gastrointestinal & hepatology (10) and Cardiovascular (7).
Where can I see NAVEGAL LABORATORIES medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.